Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Recruiting 2 Active not recruiting 2 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Lymphoid 4 CNS 3 Breast 1

Conditions

Breast Neoplasms 6391 Neoplasms 408 Ovarian Neoplasms 308 Triple Negative Breast Neoplasms 286 Prostatic Neoplasms 280 Lung Neoplasms 271 Colorectal Neoplasms 255 Neoplasm Metastasis 253 Carcinoma, Non-Small-Cell Lung 221 Breast Neoplasms, Male 201 Colonic Neoplasms 168 Motor Activity 166 Pancreatic Neoplasms 164 Melanoma 157 Carcinoma, Intraductal, Noninfiltrating 139 Stomach Neoplasms 128 Uterine Cervical Neoplasms 127 Head and Neck Neoplasms 124 Fatigue 104 Breast Carcinoma In Situ 103 Carcinoma, Ovarian Epithelial 98 Endometrial Neoplasms 96 Lymphedema 95 Carcinoma, Renal Cell 94 Urinary Bladder Neoplasms 93 Pain 90 Sarcoma 89 Small Cell Lung Carcinoma 85 Lymphoma 83 Esophageal Neoplasms 81

Interventions

patritumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Meningeal Neoplasms × Breast × Clear all

NCT05865990 2026-05-04

TUXEDO-3

MedSIR

Phase 2 Completed

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡